YOLFTbeta
Safe Orthopaedics SA

Safe Orthopaedics SA

ALSAF · PA · Healthcare / Medical Instruments & Supplies

0.64EUR+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close0.64
Open0.65
Day Range0.585 – 0.66
52-Week Range0.0022 – 2.60
Volume0
Market Cap127.51K
P/E (TTM)0.00
Forward P/E0.00
EPS-0.02
Dividend Yield0.00%
Beta-0.83
50-Day Avg0.64
200-Day Avg0.7922

About

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lumbar cage portfolio, including Cedar and Elm; and SteriSpine CC, a ready to use instrumentation for cervical cage, such as Walnut. The company was founded in 2010 and is headquartered in Fleurieux-sur-l'Arbresle, France.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Nicolas Papillon
  • Employees77
  • Headquarters80 rue Montepy, Fleurieux-sur-l'Arbresle, France, 69210, France
  • Websitehttps://www.safeorthopaedics.com

Leadership

  • Mr. Nicolas PapillonChief Executive Officer
  • Mr. Philippe LauritoCEO & Director · b. 1969
  • Mr. Thomas DrouloutCo-Founder & CTO · b. 1976
  • Mr. Rodolphe CadioAdministrative & Financial Director & Director · b. 1977

Financials

Income Statement

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue326.00K967.00K2.05K2.50K2.37K3.11K3.47K4.70M3.66M4.55M5.86M5.81M5.04M5.40M
Growth (%)-+196.63%-99.79%+21.68%-5.32%+31.50%+11.61%+135278.85%-22.15%+24.49%+28.70%-0.87%-13.24%+7.12%
Cost of Revenue521.00K953.00K1.64M2.06M1.58M1.73M1.97M8.53M2.26M1.98M10.22M1.49M11.08M1.74M
Gross Profit-195.00K14.00K4134417861.38K1.51K-3.83M-5.05M-5.74M-4.36M4.32M-6.04M3.62M
Gross Margin-59.82%1.45%20.12%17.65%33.23%44.41%43.39%-81.44%-138.11%-126.04%-74.36%74.41%-119.82%67.07%
Operating Expense3.24M3.11M5.57M7.22M6.29M5.44M6.15M3.63M1.62M1.84M1.60M12.30M-3.79M7.12M
Operating Income-3.43M-3.09M-5.57M-7.22M-6.29M-5.43M-6.15M-7.46M-6.67M-7.58M-5.96M-7.98M-2.25M-3.50M
Operating Margin-1052.76%-319.75%-271115.44%-288951.16%-265835.10%-174726.69%-177182.37%-158.69%-182.29%-166.49%-101.72%-137.31%-44.57%-64.81%
EBITDA-2.91M-2.88M-4.62M-6.07M-5.49M-6.13M-5.85M-6.37M-6.88M-5.20M-5.62M-268.17M-7.11M-3.50M
EBITDA Margin-893.56%-298.35%-224841.70%-242834.27%-232219.87%-197266.88%-168481.71%-135.60%-188.05%-114.21%-95.96%-4615.68%-141.08%-64.81%
Net Income-3.35M-3.19M-4.94M-6.57M-6.00M-6.58M-5.80M-7.97M-8.31M-6.71M-6.96M-205.44M-1.93B-4.10M
Net Income Margin-1027.91%-330.20%-240428.64%-262850.28%-253911.21%-211414.79%-167098.82%-169.61%-227.06%-147.32%-118.84%-3536.04%-38272.62%-75.93%
R&D-698.00K---700.00K800.00K-------
R&D as % of Total Revenue-72.18%---22508.04%23048.11%-------
Interest Expense23.00K51.00K22.00K29.00K14.00K26.00K23.00K1.21M861.00K638.00K355.00K218.00K2.12B512.00K
Interest Expense % of Total Revenue7.06%5.27%1071.60%1160.93%591.97%836.01%662.63%25.67%23.54%14.01%6.06%3.75%42085.50%9.48%

Balance Sheet

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.50M4.12M5.32M10.46M8.00M8.06M8.57M5.64M14.35M14.88M16.52M77.92M11.03M11.81M
Total Liabilities2.34M4.31M2.86M5.37M7.64M7.00M7.38M9.92M14.11M14.48M17.80M280.28M19.45M22.49M
Total Equity1.17M-194.00K2.46M5.09M367.00K1.06M1.19M-4.28M237.00K398.00K-1.28M-202.35M-8.42M-10.68M
Cash2.00M1.73M993.00K5.92M3.66M3.74M3.16M125.00K2.44M913.00K303.00K780.00K317.00K390.00K
Total Debt1.35M1.39M1.05M3.43M6.01M5.18M4.91M6.61M9.14M8.86M9.89M271.20M11.79M13.50M
Net Debt-651.00K-336.00K1.05M3.42M6.00M1.45M4.91M6.49M6.70M7.95M9.59M270.43M11.47M13.11M

Cash Flow

Currency: EUR2012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-2.51M-3.58M-5.05M-6.50M-5.80M-4.93M-6.21M-5.04M-5.99M-6.26M-5.47M-1.14M-3.27M-2.01M
Investing Cash Flow-623.00K-398.00K-790-525.00K-138.00K-109.00K-362-448.00K-2.99M-2.96M-858.00K-56.00K-33.00K-136.00K
Financing Cash Flow792.00K3.71M5.10M11.94M3.68M5.12M6.00M1.25M11.30M7.68M5.72M1.68M3.68M3.66M
Capital Expenditure606.00K398.00K78652214388124451.00K548.00K1.96M858.00K56.00K5.00K140.00K
Free Cash Flow-3.11M-3.98M-5.84K-7.02K-5.94K-5.02K-6.34K-5.49M-7.30M-8.81M-6.33M-1.19M-3.27M-2.15M
Dividends Paid---9.69M----------
FCF to OCF124.17%111.10%0.12%0.11%0.10%0.10%0.10%108.94%122.01%140.69%115.69%104.93%100.15%106.95%
Dividend Paid to FCF----138014.35%----------

Earnings

Report DateOct 12, 2016Jun 6, 2017Jul 11, 2017Oct 9, 2017Apr 27, 2018Sep 28, 2018Oct 8, 2018Apr 26, 2019Sep 27, 2019Oct 10, 2019May 6, 2020Jul 30, 2020Dec 28, 2020Apr 8, 2021Jul 7, 2021Oct 7, 2021Feb 15, 2022Apr 21, 2022Oct 6, 2022Jan 11, 2023Apr 13, 2023Aug 22, 2023Oct 16, 2023Feb 28, 2024Apr 29, 2024Nov 27, 2024Feb 26, 2025May 30, 2025Sep 3, 2025Dec 3, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00
EPS Actual0.00-0.13-0.200.00-0.09-0.110.00-0.08-0.090.00-5.96-2.600.00-0.71-0.870.00-1.050.00-0.520.000.000.000.000.000.00-1.79-1.790.000.000.00
Surprise------------------------------
Timing-After-hoursPre-market-Pre-marketAfter-hoursPre-marketAfter-hoursAfter-hours-Pre-marketAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursAfter-hoursAfter-hours------

Key Statistics & Ratios

Market Cap127.51K
Enterprise Value13.24M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.02
Price / Book0.40
EPS-0.02
Book Value-53.60
Revenue (TTM)5.36M
Gross Profit (TTM)3.55M
EBITDA-3.82M
Profit Margin-87.14%
Operating Margin-291.50%
Return on Equity-63940.00%
Return on Assets-23.72%
Shares Outstanding199.24K
Shares Float710.22K
Beta-0.83
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 7, 20251:1000
  • Sep 16, 20241:3000
  • Feb 27, 20231:3700
  • Jan 17, 20201:150
  • Jun 14, 20181780:1643
  • Jun 8, 2017159:139